31
Participants
Start Date
December 31, 2008
Primary Completion Date
April 30, 2013
Study Completion Date
May 31, 2013
Taliglucerase alfa
Intravenous infusion every 2 weeks
Neurogenetics, NYU at Rivergate, New York
Department of Human Genetics, Emory University School of Medicine, Decatur
Rambam Medical Center, Haifa
University Research Foundation for Lysosomal Storage Diseases, Inc., Coral Springs
Sala de Hematologia, Hospital Universitario Miguel Servet, Zaragoza
Bone Marrow Transplant Service, The Royal Melbourne Hospital, Parkville
Shaare Zedek Medical Center, Jerusalem
Lysosomal Disorders Service, Addenbrookes Hospital NHS Trust, Cambridge
Mount Sinai Hospital, Toronto
Royal Free Hospital, London
Lead Sponsor
Pfizer
INDUSTRY